Find Irsogladine Maleate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 84504-69-8, Gaslon, Mn-1695, 57381-28-9, Irsogladine (maleate), Irsogladine maleate [jan]
Molecular Formula
C13H11Cl2N5O4
Molecular Weight
372.16  g/mol
InChI Key
PJLVTVAIERNDEQ-BTJKTKAUSA-N
FDA UNII
66GVU60EPQ

Irsogladine Maleate
1 2D Structure

Irsogladine Maleate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(Z)-but-2-enedioic acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine
2.1.2 InChI
InChI=1S/C9H7Cl2N5.C4H4O4/c10-4-1-2-6(11)5(3-4)7-14-8(12)16-9(13)15-7;5-3(6)1-2-4(7)8/h1-3H,(H4,12,13,14,15,16);1-2H,(H,5,6)(H,7,8)/b;2-1-
2.1.3 InChI Key
PJLVTVAIERNDEQ-BTJKTKAUSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl.C(=CC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl.C(=C\C(=O)O)\C(=O)O
2.2 Other Identifiers
2.2.1 UNII
66GVU60EPQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine Maleate

2. 6-(2,5-dichlorophenyl)-2,4-diamino-1,3,5-triazine

3. Dcpdat

4. Irsogladine

5. Mn 1695

6. Mn-1695

2.3.2 Depositor-Supplied Synonyms

1. 84504-69-8

2. Gaslon

3. Mn-1695

4. 57381-28-9

5. Irsogladine (maleate)

6. Irsogladine Maleate [jan]

7. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine Maleate

8. 66gvu60epq

9. 84504-69-8 (maleate)

10. 1,3,5-triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-, (z)-2-butenedioate (1:1)

11. Irsogladine Hbr

12. Dsstox_cid_20234

13. Dsstox_rid_79454

14. Dsstox_gsid_40234

15. Gaslon N

16. Cas-84504-69-8

17. Unii-66gvu60epq

18. Ccris 8107

19. Iosogladine Maleate

20. Ncgc00160397-01

21. Dicloguamine Maleate

22. Gaslon N (tn)

23. Mn 1695

24. Irsogladine Maleate- Bio-x

25. Irsogladine Maleate (jp17)

26. Schembl440934

27. Chembl1712923

28. Dtxsid2040234

29. Irsogladine Maleate [mi]

30. Chebi:31721

31. Hy-b0327a

32. (z)-but-2-enedioic Acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine

33. Hms2051d03

34. Hms2230l23

35. Hms3269m05

36. Hms3413d15

37. Hms3677d15

38. Hms3714e21

39. S-triazine, 2,4-diamino-6-(2,5-dichlorophenyl)-, Maleate

40. Tox21_111786

41. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine; Maleic Acid

42. Irsogladine Maleate [who-dd]

43. Mfcd00873566

44. Akos015961793

45. Tox21_111786_1

46. Ac-6801

47. Ccg-100912

48. Hs-0056

49. Nc00162

50. Ncgc00160397-04

51. Bi164585

52. I0719

53. D01658

54. 504i698

55. A831420

56. A840825

57. Sr-01000763269-4

58. Q27263995

59. 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine Maleate

60. 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazinemaleate

61. 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine Maleat

62. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine Maleate(1:1)

63. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diaminemaleate(1:1)

64. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine (2z)-but-2-enedioate

2.4 Create Date
2005-10-11
3 Chemical and Physical Properties
Molecular Weight 372.16 g/mol
Molecular Formula C13H11Cl2N5O4
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass371.0188092 g/mol
Monoisotopic Mass371.0188092 g/mol
Topological Polar Surface Area165 Ų
Heavy Atom Count24
Formal Charge0
Complexity351
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


Anticarcinogenic Agents

Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Radiation-Protective Agents

Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty